| human | Q5 |
| P106 | occupation | researcher | Q1650915 |
| Q24296968 | A Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicity |
| Q43501182 | A rat model of progressive nigral neurodegeneration induced by the Parkinson's disease-associated G2019S mutation in LRRK2. |
| Q36577891 | Antagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating Autophagy |
| Q34286404 | Common Pathogenic Effects of Missense Mutations in the P-Type ATPase ATP13A2 (PARK9) Associated with Early-Onset Parkinsonism |
| Q21135493 | Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2. |
| Q24310218 | Functional interaction of Parkinson's disease-associated LRRK2 with members of the dynamin GTPase superfamily |
| Q21144926 | GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1 |
| Q28117134 | PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity |
| Q39536018 | Parkin promotes the ubiquitination and degradation of the mitochondrial fusion factor mitofusin 1 |
| Q28117589 | Parkinson's disease genes VPS35 and EIF4G1 interact genetically and converge on α-synuclein |
| Q34452296 | Phosphorylation of 4E-BP1 in the mammalian brain is not altered by LRRK2 expression or pathogenic mutations |
Search more.